Healthcare Services Group Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on Apr 26, 2024 and accepted by EDGAR at Apr 26, 2024, 16:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $423.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $358.9m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $46.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $6.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $15.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.21 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 74,055,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | −$26.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $2.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2024-01-01 to 2024-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $29.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $580.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $803.9m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $209.4m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-03-31 | $474.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000731012-24-000065. Last ingested by Listed: Oct 30, 2026, 13:40 ET. Listed shows no prices and gives no investment advice.